Q&A With Suvoda CEO Jagath Wanninayake: How The Suvoda–Greenphire Merger Supports A More Seamless Trial Experience

By Elena Filimonova, Chief Marketing Officer, Suvoda

Clinical trials are built around time-sensitive, patient-centered moments, such as when a patient arrives for a visit or completes a key assessment. Yet too often, disconnected technologies and fragmented processes create friction at these moments, slowing progress and straining patients and sites alike.

In this conversation, Suvoda CEO shares his perspective on how the merger of Suvoda and Greenphire represents more than just a joining of two technology companies—it’s a step toward a truly connected clinical trial experience. By uniting Suvoda’s expertise in patient scheduling, consent, and data-driven trial execution with Greenphire’s strengths in payments and travel logistics, the combined company is positioned to reduce complexity at every stage of the patient journey. The vision: a seamless ecosystem where systems communicate in real time, site teams are freed from administrative burden, and patients can focus on their health—not on logistics or paperwork.